Recurrent Pericarditis, an Unexpected Effect of Adjuvant Interferon Chemotherapy for Malignant Melanoma

Overview

Journal Case Rep Cardiol

Publisher Wiley

Specialty Cardiology & Vascular Diseases

Date 2016 Jul 16

PMID 27418981

Citations 2

Authors

Farhan Ashraf

Fady Marmoush

Muhammad Ismail Shafi

Ashish Shah

Affiliations

Soon will be listed here.

Abstract

Drug-induced pericarditis is a well-described cardiac pathology that can result from a variety of medications; however, interferon-mediated pericarditis is extremely rare. We present a case of a young female with recurrent pericarditis due to interferon therapy. The role of interferon in adjuvant chemotherapy is well known and yields good effect, but this case highlights the very uncommon phenomena of interferon induced pericarditis and the significant distress it can cause.

Citing Articles

Causes of death among patients with cutaneous melanoma: a US population-based study.

Sadeq M, Ashry M, Ghorab R, Afify A Sci Rep. 2023; 13(1):10257.

PMID: 37355743 PMC: 10290704. DOI: 10.1038/s41598-023-37333-4.

Nishio K, Arase T, Tada H, Tachibana H World J Cardiol. 2017; 9(6):553-557.

PMID: 28706591 PMC: 5491473. DOI: 10.4330/wjc.v9.i6.553.

References

Itoh Y, Okanoue T, Enjyo F, Morimoto M, Takeuchi T, Kagawa K . Elevated interleukin-6 and gamma-globulin during interferon therapy of hepatitis B. Am J Gastroenterol. 1992; 87(10):1485-7. View

Edwards B, Merritt J, Fuhlbrigge R, Borden E . Low doses of interferon alpha result in more effective clinical natural killer cell activation. J Clin Invest. 1985; 75(6):1908-13. PMC: 425547. DOI: 10.1172/JCI111905. View

Permanyer-Miralda G, Sagrista-Sauleda J, Soler-Soler J . Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol. 1985; 56(10):623-30. DOI: 10.1016/0002-9149(85)91023-9. View

Spodick D . Acute pericarditis: current concepts and practice. JAMA. 2003; 289(9):1150-3. DOI: 10.1001/jama.289.9.1150. View

Sacchi S, Kantarjian H, OBrien S, Cohen P, Pierce S, Talpaz M . Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia. J Clin Oncol. 1995; 13(9):2401-7. DOI: 10.1200/JCO.1995.13.9.2401. View

Popescu C, Arama V, Gliga S . Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - case report. BMC Gastroenterol. 2011; 11:30. PMC: 3079687. DOI: 10.1186/1471-230X-11-30. View

Boonen A, Stockbrugger R, van der Linden S . Pericarditis after therapy with interferon-alpha for chronic hepatitis C. Clin Rheumatol. 1999; 18(2):177-9. DOI: 10.1007/s100670050081. View

Dreno B, Chiffoleau A, LITOUX P . [Cardiovascular manifestations associated with interferon alfa-2A]. Ann Med Interne (Paris). 1991; 142(8):576-81. View

Teragawa H, HONDO T, Amano H, Hino F, Ohbayashi M . Adverse effects of interferon on the cardiovascular system in patients with chronic hepatitis C. Jpn Heart J. 1996; 37(6):905-15. DOI: 10.1536/ihj.37.905. View

10.

Benjamini O, Kimhi O, Lishner M . Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b. Isr Med Assoc J. 2007; 9(6):486-7. View

11.

Sonnenblick M, Rosin A . Cardiotoxicity of interferon. A review of 44 cases. Chest. 1991; 99(3):557-61. DOI: 10.1378/chest.99.3.557. View

12.

Nishio K, Konndo T, Okada S, Enchi M . Pericarditis and chronic inflammatory demyelinating polyneuropathy during therapy with pegylated interferon alfa-2a for chronic hepatitis C. World J Hepatol. 2010; 2(9):358-61. PMC: 2999299. DOI: 10.4254/wjh.v2.i9.358. View

13.

Troughton R, Asher C, Klein A . Pericarditis. Lancet. 2004; 363(9410):717-27. DOI: 10.1016/S0140-6736(04)15648-1. View

14.

Fava S, Luoni M, Stioui S . Pericarditis during interferon-alpha therapy in chronic myelogenous leukemia. Haematologica. 1996; 81(5):484. View

15.

Rauw J, Ahmed S, Petrella T . Pericardial effusion and tamponade following interferon alpha treatment for locally advanced melanoma. Med Oncol. 2011; 29(2):1304-7. DOI: 10.1007/s12032-011-9935-7. View